Analyst Ratings (USA)
Today’s updates reflect a selective analyst outlook, with confidence in software, semiconductors and payments sectors, offset by caution toward industrials, solar energy and consumer durables. Higher targets in consumer staples and travel added pockets of optimism, while downgrades and target cuts elsewhere signalled more restrained expectations. Analysts frequently retained positive ratings despite lowering targets, suggesting continued longer-term confidence alongside near-term caution.
Updates (497)
Acadian Asset Management (AAMI) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$97.00 from US$95.00.
Aclaris Therapeutics (ACRS) — Craig Hallum set a price target to US$9.00.
Aclaris Therapeutics (ACRS) — HC Wainwright reiterated its Buy rating with a price target of US$16.00.
Adagene (ADAG) — Chardan Capital reiterated its Buy rating with a price target of US$9.00.
Advanced Micro Devices (AMD) — Susquehanna maintained its Positive rating and raised its price target to US$650.00 from US$620.00.
AerSale (ASLE) — B. Riley Financial maintained its Neutral rating and lowered its price target to US$6.00 from US$7.50.
Alexandria Real Estate Equities (ARE) — BNP Paribas Exane maintained its Underperform rating and lowered its price target to US$37.00 from US$40.00.
Alexandria Real Estate Equities (ARE) — Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$42.00 from US$52.00.
Algonquin Power & Utilities (AQN) — Canadian Imperial Bank of Commerce set a price target to US$5.75.
Alignment Healthcare (ALHC) — Needham & Company LLC initiated coverage with a Hold rating.
AllianceBernstein (AB) — Sanford C. Bernstein reiterated its Hold rating with a price target of US$35.00.
AllianceBernstein (AB) — TD Cowen maintained its Hold rating and lowered its price target to US$35.00 from US$36.00.
Alnylam Pharmaceuticals (ALNY) — HC Wainwright reiterated its Buy rating.
Alpine Income Property Trust (PINE) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$20.00 from US$22.00.
Amentum (AMTM) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$25.00 from US$26.00.
American Public Education (APEI) — B. Riley Financial maintained its Buy rating and lowered its price target to US$65.00 from US$70.00.
American Tower (AMT) — Royal Bank Of Canada reiterated its Outperform rating with a price target of US$205.00.
Ameris Bancorp (ABCB) — Truist Financial maintained its Hold rating and raised its price target to US$87.00 from US$84.00.
Amphenol (APH) — Evercore set a price target to US$100.00.
Anfield Energy (AEC) — Roth Capital initiated coverage with a Buy rating with a price target of US$5.
Apple (AAPL) — Monness Crespi & Hardt reiterated its Buy rating with a price target of US$355.00.
Applied Aerospace & Defense (AADX) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$18.00 from US$21.00.
Applied Industrial Technologies (AIT) — KeyCorp maintained its Overweight rating and lowered its price target to US$360.00 from US$420.00.
Applied Industrial Technologies (AIT) — Oppenheimer reiterated its Outperform rating.
Applied Industrial Technologies (AIT) — Robert W. Baird maintained its Outperform rating and lowered its price target to US$350.00 from US$400.00.
AppLovin (APP) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$500.00 from US$575.00.
AppLovin (APP) — UBS Group set a price target to US$414.00.
Arch Capital Group (ACGL) — Citigroup reiterated its Market Outperform rating.
Ares Capital (ARCC) — Citigroup reiterated its Market Outperform rating.
Armstrong World Industries (AWI) — DA Davidson set a price target to US$200.00.
Armstrong World Industries (AWI) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$225.00.
Armstrong World Industries (AWI) — Truist Financial maintained its Buy rating and lowered its price target to US$210.00 from US$230.00.
Asbury Automotive Group (ABG) — Bank of America reiterated its Buy rating with a price target of US$232.00.
Atlas Energy Solutions (AESI) — Glj Research initiated coverage with a Buy rating with a price target of US$13.00.
Atlassian (TEAM) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$270.00 from US$230.00.
Avidbank (AVBH) — DA Davidson maintained its Buy rating and raised its price target to US$40.00 from US$38.00.
Avidity Biosciences (RNA) — HC Wainwright maintained its Buy rating and lowered its price target to US$20.00 from US$25.00.
BankUnited (BKU) — Piper Sandler maintained its Neutral rating and lowered its price target to US$44.00 from US$47.00.
Beam Therapeutics (BEAM) — Wedbush maintained its Outperform rating and lowered its price target to US$28.00 from US$65.00.
Beta Bionics (BBNX) — Piper Sandler reiterated its Overweight rating with a price target of US$24.00 from US$20.00.
Beta Bionics (BBNX) — TD Cowen maintained its Hold rating and raised its price target to US$21.00 from US$18.00.
BigBear.ai (BBAI) — Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$3.00 from US$4.00.
BigBear.ai (BBAI) — Citigroup reiterated its Market Perform rating.
Biogen (BIIB) — Barclays maintained its Equal Weight rating and raised its price target to US$230.00 from US$200.00.
Biogen (BIIB) — Citigroup reiterated its Neutral rating.
BlackRock (BLK) — Jefferies Financial Group reiterated its Buy rating with a price target of US$1,341.00.
Block (XYZ) — BTIG Research reiterated its Buy rating with a price target of US$100.00.
Boeing (BA) — Barclays maintained its Overweight rating and lowered its price target to US$250.00 from US$300.00.
Boeing (BA) — BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$205.00 from US$265.00.
Boeing (BA) — BNP Paribas Exane upgraded the stock to Neutral.
Boeing (BA) — Glj Research initiated coverage with a Buy rating.
Boeing (BA) — Jefferies Financial Group set a price target to US$230.00.
Boeing (BA) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$195.00 from US$225.00.
Boeing (BA) — Needham & Company LLC initiated coverage with a Hold rating.
Boeing (BA) — Oppenheimer downgraded the stock to Market Perform.
Boeing (BA) — Piper Sandler downgraded the stock from Overweight to Neutral.
Boeing (BA) — Robert W. Baird maintained its Outperform rating and lowered its price target to US$230.00 from US$300.00.
Boeing (BA) — Roth Capital downgraded the stock to Neutral.
Boeing (BA) — Susquehanna initiated coverage with a Positive rating with a price target of US$250.00 from US$285.00.
Boeing (BA) — TD Cowen maintained its Buy rating and lowered its price target to US$210.00 from US$240.00.
Boeing (BA) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$238.00.
Boeing (BA) — UBS Group reiterated its Buy rating.
Boeing (BA) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$210.00 from US$250.00.
Boston Scientific (BSX) — JPMorgan downgraded the stock from Overweight to Neutral with a price target of US$46.
Boston Scientific (BSX) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$48.00 from US$57.00.
Brookfield Business (BBUC) — National Bank Financial maintained its Outperform rating and lowered its price target to US$38.00 from US$42.00.
Brown & Brown (BRO) — Truist Financial maintained its Buy rating and lowered its price target to US$85.00 from US$90.00.
Byline Bancorp (BY) — Stephens maintained its Equal Weight rating and raised its price target to US$42.00 from US$40.00.
C4 Therapeutics (CCCC) — Lake Street Capital initiated coverage with a Buy rating with a price target of US$11.00.
CAE (CAE) — Royal Bank Of Canada reiterated its Outperform rating.
Camden National (CAC) — National Bank Financial set a price target to US$58.00.
Canada Goose (GOOS) — UBS Group reiterated its Neutral rating with a price target of US$9.00.
Carvana (CVNA) — Citigroup reiterated its Market Outperform rating.
Cavco Industries (CVCO) — Northland Securities initiated coverage with a Outperform rating with a price target of US$650.00.
Celcuity (CELC) — Royal Bank Of Canada downgraded the stock to Neutral.
Celestica (CLS) — Barclays maintained its Overweight rating and raised its price target to US$414.00 from US$406.00.
Celestica (CLS) — Citigroup reiterated its Buy rating with a price target of US$436.00 from US$415.00.
Celestica (CLS) — The Goldman Sachs Group reiterated its Conviction-Buy rating with a price target of US$435.00.
Cementos Pacasmayo S.A.A. (CPAC) — Scotiabank maintained its Sector Perform rating and lowered its price target to US$12.96 from US$13.00.
Centene (CNC) — Bank of America reiterated its Buy rating with a price target of US$82.00 from US$80.00.
Centene (CNC) — Barclays maintained its Overweight rating and raised its price target to US$82.00 from US$80.00.
Centene (CNC) — Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$79.00 from US$75.00.
Centene (CNC) — Mizuho set a price target to US$72.00.
Centene (CNC) — Morgan Stanley assigned a Equal Weight rating and set a price target to US$71.00 from US$66.00.
Centene (CNC) — Raymond James Financial set a price target to US$79.00.
Centene (CNC) — Robert W. Baird maintained its Neutral rating and raised its price target to US$71.00 from US$66.00.
CenterPoint Energy (CNP) — Barclays maintained its Equal Weight rating and raised its price target to US$43.00 from US$41.00.
Central Bancompany (CBC) — Piper Sandler maintained its Overweight rating and raised its price target to US$40.00 from US$37.00.
Centrus Energy (LEU) — B. Riley Financial maintained its Buy rating and lowered its price target to US$188.00 from US$295.00.
Charles Schwab (SCHW) — Evercore set a price target to US$98.00.
Cheesecake Factory (CAKE) — Stephens reiterated its Equal Weight rating with a price target of US$100.00.
Cheesecake Factory (CAKE) — Wells Fargo & Company set a price target to US$116.00.
Chemed (CHE) — Jefferies Financial Group upgraded the stock from Hold to Buy with a price target of US$620.00.
Chubb (CB) — TD Cowen maintained its Hold rating and raised its price target to US$379.00 from US$360.00.
Church & Dwight (CHD) — Oppenheimer maintained its Outperform rating and raised its price target to US$120.00 from US$115.00.
Citizens (CIZN) — Raymond James Financial reiterated its Market Perform rating.
Cloudflare (NET) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$400.00 from US$380.00.
Clover Health Investments (CLOV) — Needham & Company LLC initiated coverage with a Buy rating with a price target of US$6.00.
CMS Energy (CMS) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$73.00 from US$79.00.
Coca-Cola (KO) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$98.00 from US$95.00.
Coca-Cola (KO) — Morgan Stanley maintained its Overweight rating and raised its price target to US$103.00 from US$100.00.
Coca-Cola (KO) — TD Cowen maintained its Buy rating and raised its price target to US$104.00 from US$100.00.
Coca-Cola (KO) — UBS Group set a price target to US$106.00.
Coca-Cola (KO) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$100.00 from US$90.00.
Colliers International Group (CIGI) — Scotiabank maintained its Sector Outperform rating and lowered its price target to US$130.00 from US$145.00.
CommVault Systems (CVLT) — DA Davidson maintained its Buy rating and raised its price target to US$210.00 from US$185.00.
CommVault Systems (CVLT) — Guggenheim maintained its Buy rating and raised its price target to US$200.00 from US$175.00.
CommVault Systems (CVLT) — KeyCorp maintained its Overweight rating and raised its price target to US$200.00 from US$175.00.
CommVault Systems (CVLT) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$180.00 from US$160.00.
CommVault Systems (CVLT) — Scotiabank maintained its Sector Perform rating and raised its price target to US$180.00 from US$160.00.
CommVault Systems (CVLT) — Truist Financial reiterated its Buy rating with a price target of US$200.00 from US$182.00.
CommVault Systems (CVLT) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$185.00 from US$155.00.
Connect Biopharma (CNTB) — HC Wainwright reiterated its Buy rating.
Corning (GLW) — Barclays maintained its Equal Weight rating and raised its price target to US$132.00 from US$129.00.
Corning (GLW) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$155.00 from US$165.00.
Corning (GLW) — Truist Financial reiterated its Buy rating with a price target of US$175.00 from US$182.00.
Corning (GLW) — UBS Group reiterated its Buy rating with a price target of US$192.00.
Corpay (CPAY) — Morgan Stanley maintained its Overweight rating and raised its price target to US$460.00 from US$455.00.
CoStar Group (CSGP) — BTIG Research maintained its Buy rating and lowered its price target to US$35.00 from US$42.00.
CoStar Group (CSGP) — Citigroup reiterated its Market Outperform rating.
CoStar Group (CSGP) — Needham & Company LLC reiterated its Buy rating with a price target of US$40.00.
CoStar Group (CSGP) — The Goldman Sachs Group set a price target to US$36.00.
CoStar Group (CSGP) — Wells Fargo & Company maintained its Underweight rating and raised its price target to US$26.00 from US$25.00.
CoStar Group (CSGP) — Wells Fargo & Company set a price target to US$35.00.
Cullinan Therapeutics (CGEM) — BTIG Research maintained its Buy rating and raised its price target to US$41.00 from US$40.00.
DAQO New Energy (DQ) — Roth Capital set a price target to US$12.00.
Datadog (DDOG) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$325.00 from US$295.00.
Datavault AI (DVLT) — Maxim Group downgraded the stock from Buy to Hold.
Ducommun (DCO) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$180.00 from US$200.00.
Dynatrace (DT) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$75.00 from US$60.00.
Dyne Therapeutics (DYN) — Oppenheimer downgraded the stock from Outperform to Market Perform with a price target of US$15.00 from US$40.00.
Eagle Materials (EXP) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$207.00 from US$232.00.
Ecolab (ECL) — Citigroup reiterated its Buy rating.
Ecolab (ECL) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$310.00 from US$305.00.
Ecolab (ECL) — UBS Group set a price target to US$357.00.
Eloxx Pharmaceuticals (ELOX) — Guggenheim maintained its Buy rating and lowered its price target to US$40.00 from US$43.00.
enCore Energy (EU) — B. Riley Financial reiterated its Buy rating.
Enphase Energy (ENPH) — Barclays set a price target to US$26.00.
Enphase Energy (ENPH) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$25.00 from US$28.00.
Enphase Energy (ENPH) — Craig Hallum set a price target to US$38.00.
Enphase Energy (ENPH) — Mizuho set a price target to US$34.00.
Enphase Energy (ENPH) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$16.00 from US$24.00.
Enphase Energy (ENPH) — Northland Securities set a price target to US$37.50.
Enphase Energy (ENPH) — Oppenheimer downgraded the stock from Outperform to Market Perform.
Enphase Energy (ENPH) — Roth Capital downgraded the stock from Buy to Neutral with a price target of US$30.00.
Enphase Energy (ENPH) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$30.00 from US$41.00.
Enphase Energy (ENPH) — Sanford C. Bernstein maintained its Market Perform rating and lowered its price target to US$40.00 from US$56.00.
Enphase Energy (ENPH) — Susquehanna maintained its Neutral rating and lowered its price target to US$26.00 from US$35.00.
Enphase Energy (ENPH) — The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$40.00 from US$47.00.
Enphase Energy (ENPH) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$34.00 from US$44.00.
Equinor ASA (EQNR) — DZ Bank downgraded the stock from Buy to Hold.
Etsy (ETSY) — BTIG Research maintained its Buy rating and raised its price target to US$102.00 from US$90.00.
Etsy (ETSY) — Deutsche Bank Aktiengesellschaft reiterated its Hold rating.
Euronet Worldwide (EEFT) — Cantor Fitzgerald reiterated its Overweight rating.
Euronet Worldwide (EEFT) — DA Davidson assigned a Buy rating and set a price target to US$84.00 from US$94.00.
Euronet Worldwide (EEFT) — Stephens maintained its Equal Weight rating and lowered its price target to US$63.00 from US$71.00.
Excelerate Energy (EE) — DNB Markets set a price target to US$39.00.
Exelon (EXC) — Jefferies Financial Group reiterated its Hold rating.
ExlService (EXLS) — Needham & Company LLC maintained its Buy rating and raised its price target to US$50.00 from US$45.00.
F5 (FFIV) — Barclays maintained its Equal Weight rating and raised its price target to US$428.00 from US$397.00.
F5 (FFIV) — Evercore reiterated its Outperform rating.
F5 (FFIV) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$448.00 from US$415.00.
F5 (FFIV) — Piper Sandler downgraded the stock from Overweight to Neutral with a price target of US$461.00.
F5 (FFIV) — Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$540.00 from US$525.00.
F5 (FFIV) — Wells Fargo & Company set a price target to US$500.00.
Figma (FIG) — Citigroup reiterated its Buy rating.
First Citizens BancShares (FCNCA) — Truist Financial maintained its Hold rating and raised its price target to US$2,470.00 from US$2,323.00.
FirstSun Capital Bancorp (FSUN) — Piper Sandler maintained its Overweight rating and lowered its price target to US$45.00 from US$47.00.
FirstSun Capital Bancorp (FSUN) — Stephens maintained its Overweight rating and raised its price target to US$48.00 from US$45.00.
Five9 (FIVN) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$36.00 from US$32.00.
Flywire (FLYW) — Morgan Stanley maintained its Overweight rating and raised its price target to US$24.00 from US$22.00.
Fortis (FTS) — Canadian Imperial Bank of Commerce reiterated its Neutral rating.
Freeport-McMoRan (FCX) — Scotiabank maintained its Sector Outperform rating and lowered its price target to US$78.00 from US$80.00.
Freeport-McMoRan (FCX) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$79.00 from US$87.00.
Freshworks (FRSH) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$15.00 from US$10.00.
FTAI Aviation (FTAI) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$250.00 from US$300.00.
Galaxy Digital (GLXY) — Canaccord Genuity Group reiterated its Buy rating with a price target of US$50.00.
Galaxy Digital (GLXY) — HC Wainwright maintained its Buy rating and lowered its price target to US$36.00 from US$40.00.
GE HealthCare Technologies (GEHC) — BTIG Research maintained its Buy rating and raised its price target to US$83.00 from US$75.00.
GE Vernova (GEV) — Sanford C. Bernstein reiterated its Outperform rating with a price target of US$1,298.00.
General Motors (GM) — Tigress Financial reiterated its Strong-Buy rating with a price target of US$132.00.
Geron (GERN) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$2.50 from US$4.00.
Geron (GERN) — Wedbush reiterated its Outperform rating.
Hasbro (HAS) — UBS Group assigned a Outperform rating and set a price target to US$21.00 from US$28.00.
HCA Healthcare (HCA) — Bank of America maintained its Neutral rating and raised its price target to US$500.00 from US$450.00.
HCA Healthcare (HCA) — KeyCorp maintained its Overweight rating and raised its price target to US$490.00 from US$435.00.
HCA Healthcare (HCA) — Mizuho set a price target to US$495.00.
HCA Healthcare (HCA) — Robert W. Baird maintained its Neutral rating and raised its price target to US$409.00 from US$393.00.
HCA Healthcare (HCA) — TD Cowen maintained its Buy rating and raised its price target to US$486.00 from US$460.00.
Herc (HRI) — Barclays reiterated its Overweight rating with a price target of US$200.00.
Herc (HRI) — BNP Paribas Exane maintained its Neutral rating and raised its price target to US$176.00 from US$165.00.
Herc (HRI) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$230.00 from US$165.00.
Herc (HRI) — Robert W. Baird maintained its Outperform rating and raised its price target to US$240.00 from US$220.00.
Herc (HRI) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$200.00 from US$176.00.
Hexcel (HXL) — TD Cowen reiterated its Hold rating.
HF Sinclair (DINO) — Raymond James Financial reiterated its Outperform rating with a price target of US$50.00 from US$62.00.
Hilton Worldwide (HLT) — Morgan Stanley maintained its Overweight rating and raised its price target to US$362.00 from US$349.00.
Hilton Worldwide (HLT) — Robert W. Baird maintained its Outperform rating and raised its price target to US$362.00 from US$360.00.
Hilton Worldwide (HLT) — Susquehanna maintained its Neutral rating and raised its price target to US$360.00 from US$345.00.
Hilton Worldwide (HLT) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$390.00.
Hilton Worldwide (HLT) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$386.00 from US$383.00.
Hubbell (HUBB) — JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to US$486.00 from US$485.00.
Hubbell (HUBB) — Mizuho set a price target to US$515.00.
Hubbell (HUBB) — Robert W. Baird maintained its Outperform rating and lowered its price target to US$540.00 from US$550.00.
Hubbell (HUBB) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$525.00 from US$531.00.
HubSpot (HUBS) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$250.00 from US$200.00.
Huntington Bancshares (HBAN) — Truist Financial maintained its Buy rating and lowered its price target to US$18.00 from US$19.00.
Icon (ICLR) — Evercore reiterated its Outperform rating.
Illinois Tool Works (ITW) — Truist Financial reiterated its Hold rating with a price target of US$293.00 from US$297.00.
Independent Bank (IBCP) — DA Davidson maintained its Neutral rating and raised its price target to US$42.00 from US$40.00.
Indivior (INDV) — Barclays maintained its Overweight rating and raised its price target to US$45.00 from US$43.00.
Innio (INIO) — Citigroup reiterated its Neutral rating.
Innio (INIO) — Morgan Stanley maintained its Overweight rating and raised its price target to US$42.00 from US$40.00.
Intapp (INTA) — Citigroup reiterated its Neutral rating.
Intapp (INTA) — Oppenheimer reiterated its Market Perform rating.
Intapp (INTA) — UBS Group reiterated its Mixed rating.
Invesco (IVZ) — Barclays maintained its Equal Weight rating and raised its price target to US$33.00 from US$32.00.
IQVIA (IQV) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$325.00 from US$295.00.
IQVIA (IQV) — Truist Financial maintained its Buy rating and raised its price target to US$346.00 from US$329.00.
Itron (ITRI) — BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$105.00 from US$115.00.
Itron (ITRI) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$109.00 from US$107.00.
Itron (ITRI) — Oppenheimer reiterated its Outperform rating.
Jazz Pharmaceuticals (JAZZ) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$300.00 from US$276.00.
JFrog (FROG) — Oppenheimer maintained its Outperform rating and raised its price target to US$125.00 from US$115.00.
Johnson Controls International (JCI) — BNP Paribas Exane maintained its Underperform rating and raised its price target to US$145.00 from US$130.00.
Johnson Controls International (JCI) — Evercore set a price target to US$170.00.
Johnson Controls International (JCI) — Robert W. Baird maintained its Neutral rating and raised its price target to US$172.00 from US$162.00.
Johnson Controls International (JCI) — UBS Group reiterated its Buy rating.
Johnson Controls International (JCI) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$200.00 from US$186.00.
Karman (KRMN) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$60.00 from US$70.00.
Kimberly-Clark (KMB) — UBS Group reiterated its Neutral rating with a price target of US$113.00.
Kinder Morgan (KMI) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$38.00 from US$36.00.
Kiniksa Pharmaceuticals International (KNSA) — The Goldman Sachs Group maintained its Buy rating and raised its price target to US$101.00 from US$90.00.
Kiniksa Pharmaceuticals International (KNSA) — Wedbush maintained its Outperform rating and raised its price target to US$102.00 from US$99.00.
Kiniksa Pharmaceuticals International (KNSA) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$110.00 from US$87.00.
Klaviyo (KVYO) — Citigroup reiterated its Buy rating.
Klaviyo (KVYO) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$24.00 from US$22.00.
Kosmos Energy (KOS) — Jefferies Financial Group downgraded the stock from Buy to Hold with a price target of US$2.90.
Kratos Defense & Security Solutions (KTOS) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$55.00 from US$80.00.
Labcorp (LH) — Barclays set a price target to US$380.00.
Labcorp (LH) — Leerink Partners set a price target to US$410.00.
Lakeland Financial (LKFN) — Stephens maintained its Equal Weight rating and raised its price target to US$67.00 from US$66.00.
Lakewood-Amedex Biotherapeutics (LABT) — H.C. Wainwright initiated coverage with a Buy rating with a price target of US$3.
Lamar Advertising (LAMR) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$156.00 from US$151.00.
Landstar System (LSTR) — Evercore set a price target to US$182.00.
Landstar System (LSTR) — Raymond James Financial reiterated its Market Perform rating.
Landstar System (LSTR) — Robert W. Baird maintained its Outperform rating and lowered its price target to US$195.00 from US$215.00.
Landstar System (LSTR) — Stephens maintained its Overweight rating and lowered its price target to US$210.00 from US$215.00.
Landstar System (LSTR) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$179.00 from US$197.00.
Landstar System (LSTR) — Truist Financial maintained its Hold rating and lowered its price target to US$160.00 from US$175.00.
Landstar System (LSTR) — UBS Group set a price target to US$185.00.
Landstar System (LSTR) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$215.00 from US$225.00.
Liftoff Mobile (LFTO) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$21.00 from US$34.00.
Lincoln Educational Services (LINC) — B. Riley Financial maintained its Buy rating and lowered its price target to US$52.00 from US$56.00.
Lincoln Electric (LECO) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$293.00 from US$283.00.
Lincoln Electric (LECO) — Robert W. Baird maintained its Outperform rating and raised its price target to US$322.00 from US$317.00.
Lincoln Electric (LECO) — Stifel Nicolaus maintained its Hold rating and raised its price target to US$290.00 from US$271.00.
Lincoln Electric (LECO) — UBS Group reiterated its Buy rating with a price target of US$360.00.
Logitech International (LOGI) — Barclays maintained its Equal Weight rating and raised its price target to US$110.00 from US$101.00.
Logitech International (LOGI) — Morgan Stanley maintained its Underweight rating and raised its price target to US$94.00 from US$90.00.
LPL Financial (LPLA) — Barclays maintained its Overweight rating and lowered its price target to US$372.00 from US$409.00.
LPL Financial (LPLA) — TD Cowen maintained its Hold rating and lowered its price target to US$356.00 from US$380.00.
LPL Financial (LPLA) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$400.00.
LPL Financial (LPLA) — Truist Financial maintained its Hold rating and lowered its price target to US$335.00 from US$354.00.
LPL Financial (LPLA) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$350.00 from US$362.00.
Manhattan Associates (MANH) — DA Davidson maintained its Neutral rating and raised its price target to US$230.00 from US$210.00.
Manhattan Associates (MANH) — Stifel Nicolaus maintained its Buy rating and raised its price target to US$300.00 from US$250.00.
Manhattan Associates (MANH) — Truist Financial reiterated its Buy rating with a price target of US$305.00 from US$240.00.
Manhattan Associates (MANH) — UBS Group set a price target to US$305.00.
Manulife Financial (MFC) — Scotiabank downgraded the stock from Sector Outperform to Sector Perform.
Martin Marietta Materials (MLM) — Stifel Nicolaus maintained its Buy rating and lowered its price target to US$629.00 from US$634.00.
Marzetti (MZTI) — Stephens maintained its Equal Weight rating and lowered its price target to US$135.00 from US$140.00.
Match Group (MTCH) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$39.00 from US$40.00.
Mercury Systems (MRCY) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$105.00 from US$120.00.
MidCap Financial Investment (MFIC) — Raymond James Financial downgraded the stock from Outperform to Market Perform.
Monarch Casino & Resort (MCRI) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$123.00 from US$128.00.
MSG Rangers Corp (MSGR) — Guggenheim initiated coverage with a Buy rating with a price target of US$278.
National Research (NRC) — Citizens Jmp maintained its Market Outperform rating and raised its price target to US$27.00 from US$26.00.
Neurogene (NGNE) — HC Wainwright reiterated its Buy rating with a price target of US$8.00 from US$10.00.
Noble (NE) — Susquehanna maintained its Neutral rating and raised its price target to US$46.00 from US$44.00.
Northern Oil and Gas (NOG) — Raymond James Financial reiterated its Outperform rating with a price target of US$34.00.
Novartis (NVS) — Morgan Stanley reiterated its Overweight rating with a price target of US$163.00.
Novartis (NVS) — Royal Bank Of Canada reiterated its Sector Perform rating.
Novartis (NVS) — UBS Group reiterated its Neutral rating.
NRG Energy (NRG) — Canadian Imperial Bank of Commerce set a price target to US$159.00.
NRG Energy (NRG) — Scotiabank maintained its Sector Outperform rating and lowered its price target to US$149.00 from US$162.00.
NRG Energy (NRG) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$182.00 from US$209.00.
Nucor (NUE) — Barclays maintained its Overweight rating and raised its price target to US$320.00 from US$306.00.
Nucor (NUE) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$304.00 from US$296.00.
Nucor (NUE) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$335.00.
Nucor (NUE) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$305.00 from US$280.00.
NuScale Power (SMR) — B. Riley Financial maintained its Buy rating and lowered its price target to US$10.00 from US$15.00.
Nutrien (NTR) — Raymond James Financial maintained its Outperform rating and lowered its price target to US$83.00 from US$90.00.
nVent Electric (NVT) — Roth Capital set a price target to US$200.00.
NXP Semiconductors (NXPI) — Bank of America reiterated its Neutral rating with a price target of US$280.00.
NXP Semiconductors (NXPI) — Citigroup reiterated its Neutral rating.
NXP Semiconductors (NXPI) — Evercore reiterated its Outperform rating.
NXP Semiconductors (NXPI) — Jefferies Financial Group reiterated its Buy rating.
NXP Semiconductors (NXPI) — KeyCorp maintained its Overweight rating and lowered its price target to US$330.00 from US$345.00.
NXP Semiconductors (NXPI) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$313.00 from US$338.00.
NXP Semiconductors (NXPI) — Needham & Company LLC reiterated its Buy rating with a price target of US$300.00.
NXP Semiconductors (NXPI) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$250.00 from US$265.00.
NXP Semiconductors (NXPI) — TD Cowen maintained its Buy rating and raised its price target to US$280.00 from US$275.00.
NXP Semiconductors (NXPI) — Truist Financial maintained its Buy rating and lowered its price target to US$300.00 from US$310.00.
NXP Semiconductors (NXPI) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$245.00 from US$235.00.
OGE Energy (OGE) — Scotiabank reiterated its Outperform rating with a price target of US$54.00.
Oklo (OKLO) — B. Riley Financial maintained its Buy rating and lowered its price target to US$61.00 from US$92.00.
Omada Health (OMDA) — Barclays maintained its Overweight rating and lowered its price target to US$24.00 from US$27.00.
ON (ONON) — BMO Capital Markets reiterated its Market Perform rating with a price target of US$35.00.
OneSpaWorld (OSW) — Jefferies Financial Group reiterated its Buy rating with a price target of US$40.00.
Oric Pharmaceuticals (ORIC) — BTIG Research reiterated its Buy rating with a price target of US$26.00.
OrthoPediatrics (KIDS) — BTIG Research maintained its Buy rating and raised its price target to US$30.00 from US$29.00.
OrthoPediatrics (KIDS) — Canaccord Genuity Group set a price target to US$30.00.
OrthoPediatrics (KIDS) — Lake Street Capital reiterated its Buy rating with a price target of US$38.00.
OrthoPediatrics (KIDS) — Needham & Company LLC reiterated its Buy rating with a price target of US$35.00.
OrthoPediatrics (KIDS) — Piper Sandler reiterated its Overweight rating with a price target of US$30.00 from US$25.00.
OrthoPediatrics (KIDS) — Stifel Nicolaus maintained its Buy rating and raised its price target to US$27.00 from US$24.00.
OrthoPediatrics (KIDS) — TD Cowen maintained its Buy rating and raised its price target to US$28.00 from US$23.00.
OrthoPediatrics (KIDS) — Truist Financial maintained its Hold rating and raised its price target to US$28.00 from US$22.00.
Ovintiv (OVV) — National Bank Financial maintained its Outperform rating and raised its price target to US$95.00 from US$94.00.
PACCAR (PCAR) — Truist Financial maintained its Hold rating and lowered its price target to US$124.00 from US$125.00.
Palantir Technologies (PLTR) — Royal Bank Of Canada reiterated its Underperform rating.
Palvella Therapeutics (PVLA) — Chardan Capital reiterated its Buy rating with a price target of US$240.00.
Park National (PRK) — Piper Sandler maintained its Neutral rating and lowered its price target to US$201.00 from US$217.00.
Paycom Software (PAYC) — KeyCorp maintained its Overweight rating and raised its price target to US$295.00 from US$280.00.
Paylocity (PCTY) — KeyCorp maintained its Overweight rating and raised its price target to US$190.00 from US$178.00.
PayPal (PYPL) — Bank of America maintained its Underperform rating and raised its price target to US$54.00 from US$53.00.
PayPal (PYPL) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$59.00 from US$56.00.
PayPal (PYPL) — Canaccord Genuity Group reiterated its Hold rating with a price target of US$55.00.
PayPal (PYPL) — Morgan Stanley maintained its Underweight rating and raised its price target to US$46.00 from US$45.00.
PayPal (PYPL) — TD Cowen maintained its Hold rating and raised its price target to US$60.00 from US$59.00.
PayPal (PYPL) — UBS Group reiterated its Neutral rating with a price target of US$60.00.
Pentair (PNR) — BNP Paribas Exane upgraded the stock from Underperform to Neutral with a price target of US$65.00.
Pentair (PNR) — Citigroup reiterated its Buy rating.
Pentair (PNR) — Robert W. Baird set a price target to US$78.00.
Pentair (PNR) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$69.00 from US$61.00.
Pentair (PNR) — The Goldman Sachs Group set a price target to US$66.00.
Pentair (PNR) — UBS Group set a price target to US$65.00.
Pharming Group (PHAR) — Oppenheimer reiterated its Outperform rating.
Phoenix Education Partners (PXED) — B. Riley Financial maintained its Buy rating and lowered its price target to US$44.00 from US$51.00.
Pinnacle Financial Partners (PNFP) — Truist Financial maintained its Buy rating and raised its price target to US$120.00 from US$112.00.
Pinterest (PINS) — KeyCorp maintained its Overweight rating and lowered its price target to US$28.00 from US$30.00.
Polaris (PII) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$72.00 from US$75.00.
Precision Drilling (PDS) — BMO Capital Markets reiterated its Outperform rating.
Principal Financial Group (PFG) — Evercore set a price target to US$111.00.
Principal Financial Group (PFG) — Piper Sandler maintained its Overweight rating and lowered its price target to US$125.00 from US$128.00.
Principal Financial Group (PFG) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$109.00 from US$112.00.
Procore Technologies (PCOR) — Griffin Securities initiated coverage with a Buy rating with a price target of US$82.00.
Prudential Financial (PRU) — Wells Fargo & Company maintained its Underweight rating and lowered its price target to US$103.00 from US$104.00.
Public Storage (PSA) — Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$323.00 from US$318.00.
Pulmonx (LUNG) — Canaccord Genuity Group set a price target to US$5.00.
Pulmonx (LUNG) — Stifel Nicolaus maintained its Buy rating and raised its price target to US$4.00 from US$2.50.
Qiagen (QGEN) — Barclays downgraded the stock from Overweight to Equal Weight with a price target of US$53.00 from US$55.00.
Ralph Lauren (RL) — UBS Group reiterated its Buy rating with a price target of US$521.00.
Repligen (RGEN) — Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$200.00 from US$185.00.
Revolve Group (RVLV) — BTIG Research reiterated its Buy rating with a price target of US$35.00.
Ribbon Communications (RBBN) — B. Riley Financial reiterated its Buy rating with a price target of US$3.10 from US$3.30.
Ribbon Communications (RBBN) — Rosenblatt Securities maintained its Neutral rating and lowered its price target to US$1.80 from US$2.20.
Robinhood Markets (HOOD) — Barclays maintained its Overweight rating and lowered its price target to US$115.00 from US$132.00.
Robinhood Markets (HOOD) — BTIG Research reiterated its Buy rating with a price target of US$135.00.
Robinhood Markets (HOOD) — Citizens Jmp reiterated its Market Outperform rating with a price target of US$165.00.
Robinhood Markets (HOOD) — KeyCorp maintained its Overweight rating and lowered its price target to US$135.00 from US$140.00.
Robinhood Markets (HOOD) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$116.00 from US$126.00.
Robinhood Markets (HOOD) — Rosenblatt Securities reiterated its Buy rating with a price target of US$135.00.
Robinhood Markets (HOOD) — Scotiabank maintained its Sector Outperform rating and lowered its price target to US$124.00 from US$136.00.
Robinhood Markets (HOOD) — The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$128.00 from US$145.00.
Robinhood Markets (HOOD) — Truist Financial maintained its Buy rating and lowered its price target to US$125.00 from US$134.00.
Robinhood Markets (HOOD) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$100.00 from US$120.00.
Roblox (RBLX) — BTIG Research maintained its Sell rating and raised its price target to US$42.00 from US$41.00.
Rocky Brands (RCKY) — BTIG Research reiterated its Neutral rating.
Rocky Brands (RCKY) — Robert W. Baird maintained its Neutral rating and raised its price target to US$52.00 from US$50.00.
Royal Caribbean Cruises (RCL) — Barclays maintained its Overweight rating and raised its price target to US$350.00 from US$337.00.
Royal Caribbean Cruises (RCL) — Susquehanna maintained its Positive rating and raised its price target to US$360.00 from US$355.00.
Royal Caribbean Cruises (RCL) — The Goldman Sachs Group reiterated its Buy rating with a price target of US$358.00.
Royal Caribbean Cruises (RCL) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$361.00 from US$358.00.
Ryanair (RYAAY) — Oddo Bhf downgraded the stock from Outperform to Underperform.
S&P Global (SPGI) — Citigroup reiterated its Buy rating.
S&P Global (SPGI) — Evercore reiterated its Outperform rating.
S&P Global (SPGI) — Morgan Stanley maintained its Overweight rating and raised its price target to US$515.00 from US$477.00.
S&P Global (SPGI) — Wells Fargo & Company maintained its Overweight rating and raised its price target to US$545.00 from US$525.00.
Scorpio Tankers (STNG) — BTIG Research reiterated its Buy rating with a price target of US$110.00.
Seagate Technology (STX) — Evercore reiterated its Outperform rating.
Seagate Technology (STX) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$1,148.00 from US$1,200.00.
Seagate Technology (STX) — Robert W. Baird set a price target to US$1,350.00.
Seagate Technology (STX) — Summit Insights downgraded the stock from Buy to Hold.
Seagate Technology (STX) — Susquehanna maintained its Neutral rating and lowered its price target to US$765.00 from US$925.00.
Seagate Technology (STX) — TD Cowen maintained its Buy rating and lowered its price target to US$900.00 from US$1,000.00.
Seagate Technology (STX) — UBS Group reiterated its Neutral rating with a price target of US$750.00.
Seagate Technology (STX) — Wedbush reiterated its Outperform rating with a price target of US$1,000.00.
Seagate Technology (STX) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$820.00 from US$865.00.
Sensata Technologies (ST) — Truist Financial maintained its Buy rating and lowered its price target to US$57.00 from US$58.00.
SharkNinja (SN) — Piper Sandler maintained its Overweight rating and raised its price target to US$234.00 from US$200.00.
Sherwin-Williams (SHW) — Barclays assigned a Equal Weight rating and set a price target to US$329.00 from US$348.00.
Sherwin-Williams (SHW) — DA Davidson assigned a Buy rating and set a price target to US$390.00 from US$400.00.
Sherwin-Williams (SHW) — Guggenheim reiterated its Buy rating with a price target of US$375.00 from US$400.00.
Sherwin-Williams (SHW) — UBS Group reiterated its Neutral rating with a price target of US$370.00.
Silicon Motion Technology (SIMO) — China Renaissance initiated coverage with a Buy rating with a price target of US$300.00.
Simply Good Foods (SMPL) — Jefferies Financial Group downgraded the stock from Buy to Hold with a price target of US$11.00.
Simply Good Foods (SMPL) — Stifel Nicolaus maintained its Buy rating and lowered its price target to US$18.00 from US$20.00.
Simply Good Foods (SMPL) — UBS Group reiterated its Neutral rating, and set a price target to US$11.00.
SK hynix (SKHY) — Needham & Company LLC maintained its Buy rating and raised its price target to US$235.00 from US$220.00.
SK hynix (SKHY) — Rosenblatt Securities maintained its Buy rating and raised its price target to US$400.00 from US$320.00.
SK hynix (SKHY) — Royal Bank Of Canada reiterated its Outperform rating with a price target of US$200.00.
SK hynix (SKHY) — Wells Fargo & Company reiterated its Buy rating.
SK hynix (SKHY) — Wolfe Research reiterated its Outperform rating.
Slide Insurance (SLDE) — Barclays maintained its Overweight rating and raised its price target to US$30.00 from US$28.00.
Slide Insurance (SLDE) — Citizens Jmp maintained its Market Outperform rating and raised its price target to US$33.00 from US$28.00.
Smithfield Foods (SFD) — Barclays maintained its Overweight rating and lowered its price target to US$23.00 from US$29.00.
Smithfield Foods (SFD) — Stephens reiterated its Reduce rating.
Smithfield Foods (SFD) — Stephens maintained its Equal Weight rating and lowered its price target to US$20.00 from US$22.00.
SoFi Technologies (SOFI) — Bank of America reiterated its Underperform rating with a price target of US$16.50.
SoFi Technologies (SOFI) — Benchmark reiterated its Sector Outperform rating.
SoFi Technologies (SOFI) — Keefe, Bruyette & Woods maintained its Underperform rating and raised its price target to US$16.00 from US$15.00.
SoFi Technologies (SOFI) — Needham & Company LLC reiterated its Buy rating with a price target of US$24.00.
SoFi Technologies (SOFI) — Scotiabank reiterated its Sector Outperform rating with a price target of US$26.00 from US$25.00.
SoFi Technologies (SOFI) — TD Cowen maintained its Hold rating and raised its price target to US$18.00 from US$17.50.
SoFi Technologies (SOFI) — Wells Fargo & Company reiterated its Negative rating.
SoFi Technologies (SOFI) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$18.00 from US$17.00.
SoftBank Group (SFTBY) — Jefferies upgraded the stock from Underperform to Hold.
Solventum (SOLV) — CIBC set a price target to US$35.00.
Spero Therapeutics (SPRO) — Cantor Fitzgerald initiated coverage with a Buy rating with a price target of US$118.00 from US$113.00.
StandardAero (SARO) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$32.00 from US$34.00.
Sun Communities (SUI) — Evercore reiterated its Outperform rating.
Sun Life Financial (SLF) — Scotiabank upgraded the stock from Sector Perform to Sector Outperform.
Sweetgreen (SG) — UBS Group reiterated its Neutral rating with a price target of US$11.00.
Talen Energy (TLN) — CIBC reiterated its Outperform rating with a price target of US$493.00.
Talen Energy (TLN) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$479.00 from US$501.00.
TAT Technologies (TATT) — B. Riley Financial maintained its Buy rating and lowered its price target to US$60.00 from US$65.00.
Texas Instruments (TXN) — DZ Bank upgraded the stock from Sell to Hold with a price target of US$300.00.
Thomson Reuters (TRI) — Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$130.00 from US$124.00.
Thryv (THRY) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$2.00 from US$3.00.
Titan America (TTAM) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$17.00 from US$19.00.
TPG RE Finance Trust (TRTX) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$8.00 from US$9.00.
TransUnion (TRU) — Needham & Company LLC maintained its Buy rating and raised its price target to US$95.00 from US$85.00.
TransUnion (TRU) — Robert W. Baird set a price target to US$99.00.
TransUnion (TRU) — Stifel Nicolaus maintained its Buy rating and lowered its price target to US$90.00 from US$96.00.
TransUnion (TRU) — The Goldman Sachs Group maintained its Neutral rating and raised its price target to US$78.00 from US$68.00.
TransUnion (TRU) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$96.00 from US$102.00.
Travel + Leisure (TNL) — Barclays maintained its Equal Weight rating and lowered its price target to US$72.00 from US$77.00.
Travel + Leisure (TNL) — Mizuho set a price target to US$108.00.
Ultra Clean (UCTT) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$80.00 from US$125.00.
Ultra Clean (UCTT) — TD Cowen maintained its Buy rating and lowered its price target to US$100.00 from US$140.00.
Ultra Clean (UCTT) — UBS Group reiterated its Buy rating.
Under Armour (UAA) — UBS Group reiterated its Buy rating.
United Parcel Service (UPS) — Bank of America maintained its Neutral rating and raised its price target to US$114.00 from US$108.00.
United Parcel Service (UPS) — Barclays maintained its Underweight rating and raised its price target to US$95.00 from US$80.00.
United Parcel Service (UPS) — Oppenheimer maintained its Outperform rating and raised its price target to US$119.00 from US$117.00.
United Parcel Service (UPS) — TD Cowen maintained its Hold rating and raised its price target to US$116.00 from US$115.00.
United Parcel Service (UPS) — Truist Financial maintained its Buy rating and raised its price target to US$120.00 from US$115.00.
United Parcel Service (UPS) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$112.00 from US$110.00.
Universal Technical Institute (UTI) — B. Riley Financial maintained its Buy rating and lowered its price target to US$45.00 from US$48.00.
Urogen Pharma (URGN) — Oppenheimer reiterated its Outperform rating.
V.F. (VFC) — BTIG Research reiterated its Buy rating with a price target of US$23.00.
V2X (VVX) — Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$81.00 from US$88.00.
Veeva Systems (VEEV) — Barclays maintained its Overweight rating and raised its price target to US$375.00 from US$360.00.
Victory Capital (VCTR) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$119.00 from US$115.00.
Visa (V) — Barclays maintained its Overweight rating and raised its price target to US$440.00 from US$420.00.
Visa (V) — BMO Capital Markets assigned a Outperform rating and set a price target to US$438.00 from US$425.00.
Visa (V) — Cantor Fitzgerald reiterated its Overweight rating.
Visa (V) — Evercore set a price target to US$405.00.
Visa (V) — Morgan Stanley reiterated its Overweight rating with a price target of US$471.00 from US$416.00.
Visa (V) — Oppenheimer maintained its Outperform rating and raised its price target to US$440.00 from US$403.00.
Visa (V) — Piper Sandler reiterated its Overweight rating with a price target of US$479.00 from US$430.00.
Visa (V) — Raymond James Financial reiterated its Outperform rating with a price target of US$445.00.
Visa (V) — Royal Bank Of Canada reiterated its Outperform rating with a price target of US$466.00.
Visa (V) — TD Cowen reiterated its Buy rating with a price target of US$450.00 from US$420.00.
Visteon (VC) — Barclays maintained its Overweight rating and lowered its price target to US$105.00 from US$125.00.
Vistra (VST) — Canadian Imperial Bank of Commerce set a price target to US$181.00.
Vistra (VST) — Scotiabank maintained its Sector Outperform rating and lowered its price target to US$189.00 from US$207.00.
Vistra (VST) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$198.00 from US$212.00.
VSE (VSEC) — B. Riley Financial maintained its Buy rating and lowered its price target to US$265.00 from US$280.00.
VSE (VSEC) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$220.00 from US$265.00.
Vulcan Materials (VMC) — Stifel Nicolaus maintained its Buy rating and lowered its price target to US$320.00 from US$333.00.
W.P. Carey (WPC) — BMO Capital Markets reiterated its Outperform rating.
Wendy’s (WEN) — TD Cowen reiterated its Hold rating with a price target of US$6.00.
Werner Enterprises (WERN) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$52.00 from US$55.00.
Werner Enterprises (WERN) — Stephens maintained its Overweight rating and lowered its price target to US$38.00 from US$46.00.
Werner Enterprises (WERN) — Stifel Nicolaus maintained its Hold rating and lowered its price target to US$36.00 from US$40.00.
Werner Enterprises (WERN) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$31.00 from US$35.00.
Whirlpool (WHR) — Royal Bank Of Canada maintained its Underperform rating and lowered its price target to US$15.00 from US$22.00.
Whirlpool (WHR) — Stifel Nicolaus downgraded the stock from Hold to Sell with a price target of US$20.00 from US$30.00.
Whirlpool (WHR) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$24.00 from US$30.00.
WisdomTree (WT) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$25.00 from US$27.00.
Woodward (WWD) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$380.00 from US$430.00.
Wyndham Hotels & Resorts (WH) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$94.00 from US$97.00.
Xylem (XYL) — BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$135.00 from US$145.00.
Xylem (XYL) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral with a price target of US$90.00 from US$118.00.
Xylem (XYL) — Mizuho set a price target to US$99.00.
Xylem (XYL) — Oppenheimer maintained its Outperform rating and lowered its price target to US$135.00 from US$150.00.
Xylem (XYL) — Robert W. Baird set a price target to US$123.00.
Xylem (XYL) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$125.00 from US$135.00.
Xylem (XYL) — Stifel Nicolaus maintained its Buy rating and lowered its price target to US$114.00 from US$141.00.
Xylem (XYL) — The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$138.00 from US$160.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business
STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)
Bank of Canada Looks to Pause rates as Recession Looms
American Analyst Updates: Oct 27th, 2026
American Analyst Updates: Oct 26th, 2026
American Analyst Updates
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.